Quantifying drug combination synergy along potency and efficacy axes CT Meyer, DJ Wooten, BB Paudel, J Bauer, KN Hardeman, D Westover, ... Cell systems 8 (2), 97-108. e16, 2019 | 156 | 2019 |
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers DJ Wooten, SM Groves, DR Tyson, Q Liu, JS Lim, R Albert, CF Lopez, ... PLoS computational biology 15 (10), e1007343, 2019 | 90 | 2019 |
Novel hybrid phenotype revealed in small cell lung cancer by a transcription factor network model that can explain tumor heterogeneity AR Udyavar, DJ Wooten, M Hoeksema, M Bansal, A Califano, L Estrada, ... Cancer Research 77 (5), 1063-1074, 2017 | 74 | 2017 |
Charting the fragmented landscape of drug synergy CT Meyer, DJ Wooten, CF Lopez, V Quaranta Trends in pharmacological sciences 41 (4), 266-280, 2020 | 64 | 2020 |
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery DJ Wooten, CT Meyer, ALR Lubbock, V Quaranta, CF Lopez Nature communications 12 (1), 4607, 2021 | 51 | 2021 |
Ventricular-subventricular zone contact by glioblastoma is not associated with molecular signatures in bulk tumor data AM Mistry, DJ Wooten, LT Davis, BC Mobley, V Quaranta, RA Ihrie Scientific Reports 9 (1), 1842, 2019 | 33 | 2019 |
synergy: a Python library for calculating, analyzing and visualizing drug combination synergy DJ Wooten, R Albert Bioinformatics 37 (10), 1473-1474, 2021 | 31 | 2021 |
Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again! DJ Wooten, V Quaranta Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1867 (2), 167-175, 2017 | 29 | 2017 |
Mathematical modeling of the Candida albicans yeast to hyphal transition reveals novel control strategies DJ Wooten, JGT Zañudo, D Murrugarra, AM Perry, A Dongari-Bagtzoglou, ... PLoS computational biology 17 (3), e1008690, 2021 | 19 | 2021 |
Data-driven math model of FLT3-ITD acute myeloid leukemia reveals potential therapeutic targets DJ Wooten, M Gebru, HG Wang, R Albert Journal of personalized medicine 11 (3), 193, 2021 | 10 | 2021 |
A consensus framework unifies multi-drug synergy metrics DJ Wooten, CT Meyer, V Quaranta, C Lopez BioRxiv, 683433, 2019 | 10 | 2019 |
Selenium induces pancreatic cancer cell death alone and in combination with gemcitabine DJ Wooten, I Sinha, R Sinha Biomedicines 10 (1), 149, 2022 | 6 | 2022 |
Quantifying drug combination synergy along potency and efficacy axes. Cell Syst. 2019; 8: 97–108. e16 CT Meyer, DJ Wooten, BB Paudel, J Bauer, KN Hardeman, D Westover, ... | 6 | |
Correction: Novel Hybrid. Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model. That Can Explain Tumor Heterogeneity AR Udyavar, DJ Wooten, M Hoeksema, M Bansal, A Califano, L Estrada, ... Cancer Res 79 (1014), 10.1158, 2019 | 3 | 2019 |
Small cell lung cancer subtypes identified by systems-level modeling of transcription factor networks D Wooten, S Maddox, D Tyson, Q Liu, JS Lim, J Sage, V Quaranta Preprint at bioRxiv https://www. biorxiv. org/content/10.1101/506402v2, 2018 | 2 | 2018 |
A transcription factor network model explains heterogeneity and reveals a novel hybrid phenotype in Small-Cell Lung Cancer AR Udyavar, DJ Wooten, M Hoeksema, M Bansal, A Califano, L Estrada, ... Cancer research 77 (5), 1063, 2017 | 1 | 2017 |
Methods for evaluating therapeutic benefit of combination therapies CT Meyer, V Quaranta, LA Harris, BB Paudel, DJ Wooten, L Audoly US Patent App. 17/180,280, 2021 | | 2021 |
Yutong Sha1, 2, Shuxiong Wang1, Federico Bocci1, 2, Peijie Zhou1* and Qing Nie1, 2, 3 A Sharma, W Wang, DJ Wooten, FF Clos, P Zhou, Q Nie, Y Sha, S Wang, ... Non-Genetic Heterogeneity in Development and Disease, 2021 | | 2021 |
Synergy DJ Wooten, R Albert | | 2021 |
PATH-34. VENTRICULAR-SUBVENTRICULAR ZONE CONTACT BY GLIOBLASTOMA IS NOT ASSOCIATED WITH MOLECULAR SIGNATURES IN BULK TUMOR DATA A Mistry, D Wooten, B Mobley, V Quaranta, R Ihrie Neuro-Oncology 20 (Suppl 6), vi166, 2018 | | 2018 |